Sihyug Jang Email

Senior Scientist . TeraImmune

Current Roles

Employees:
2
Revenue:
$310k
About
Key technical assets of TeraImmune 1) Expansion of human regulatory T cells in vitro 2) Receptors targeting pathological immune cells (T cell/ B cell/ antigen presenting cell) Grant awards 1) SBIR phase 1 (NHLBI, NIH) in April 2018 - grant for small businesses, scientifically verified 2) PACT program (NHLBI, NIH) in November 2018 - service grant supporting overall process development of the cell manufacturing: establishment of standard operating procedure (SOP), QA/QC and regulatory service
TeraImmune Address
9610 Medical Center Dr.
Gaithersburg, MD
TeraImmune Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.